The protective effect of MT1 in PD was recently identified through an artificial transducing experiment, in which human MT1A was transduced into mitochondria by a cell-penetrating artificial mitochondria-targeting peptide (CAMP) (103). The gene discussed is MT1B; the disease is Parkinson disease.